A Randomized, Double-blinded, Single-dose, 3-arm Parallel, Comparative Study to Evaluate the Pharmacokinetics and Safety of BAT1806 Injection vs Actemra® in Healthy Chinese Male Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Bio-Thera Solutions
- 26 Jul 2018 According to a Bio-Thera Solutions media release, dosing has begun in this trial.
- 26 Jul 2018 Status changed from not yet recruiting to recruiting, according to a Bio-Thera Solutions media release.
- 06 Apr 2018 New trial record